Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China flag China · Delayed Price · Currency is CNY
4.730
-0.010 (-0.21%)
Jun 18, 2026, 3:00 PM CST

SHA:600613 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
482.37594.09779.39715.28656.49493.8
Short-Term Investments
-80.75----
Trading Asset Securities
232.7110.420.8720.9--
Cash & Short-Term Investments
715.07785.24800.27736.17656.49493.8
Cash Growth
-10.20%-1.88%8.71%12.14%32.95%2.56%
Accounts Receivable
614.82642.7529.62750.25813.82675.75
Other Receivables
10.68.94.89.7411.0920.38
Receivables
625.42651.6534.42759.99824.91696.12
Inventory
217.63197.5228.34242.86218.82205.13
Other Current Assets
21.0919.5732.8833.2369.6750.8
Total Current Assets
1,5791,6541,5961,7721,7701,446
Property, Plant & Equipment
1,0141,0311,0541,0521,1001,167
Long-Term Investments
77.9586.1987.0274.1467.3383.08
Goodwill
243.85243.85243.85243.85299.06299.06
Other Intangible Assets
92.7293.396.6595.298.91104.81
Long-Term Deferred Tax Assets
25.7725.2223.1723.4436.0228.83
Long-Term Deferred Charges
2.292.331.641.631.852.3
Other Long-Term Assets
8.579.4613.2116.6612.8518.13
Total Assets
3,0443,1453,1163,2793,3863,149
Accounts Payable
234.8241.9223.85249.85186.8188.31
Accrued Expenses
15.2534.3829.2131.9849.7625.89
Short-Term Debt
61.7361.9127.031821.082.72
Current Portion of Long-Term Debt
16.9538.2840.7436.9235.6836
Current Portion of Leases
-8.399.3311.028.6615.74
Current Income Taxes Payable
18.554.345.112.247.910.04
Current Unearned Revenue
47.6535.5835.429.6782.8345.06
Other Current Liabilities
210.66196.04160.21306.36381.62156.04
Total Current Liabilities
605.59620.82530.88686.04774.34479.81
Long-Term Debt
-88.56129.58170.1207.7242.9
Long-Term Leases
11.5112.3510.4517.0312.4814.92
Long-Term Unearned Revenue
8.618.841.651.261.533.02
Long-Term Deferred Tax Liabilities
15.2717.0216.4514.3418.2415.81
Total Liabilities
640.98747.59689.01888.771,014756.45
Common Stock
534.07534.07534.07534.07534.07534.07
Additional Paid-In Capital
968.99968.99968.99968.99968.99968.99
Retained Earnings
800.25787.37829.24811.25807.79813.1
Comprehensive Income & Other
23.7329.930.7421.0716.2628.12
Total Common Equity
2,3272,3202,3632,3352,3272,344
Minority Interest
76.3477.263.7755.1844.7348.23
Shareholders' Equity
2,4032,3982,4272,3912,3722,393
Total Liabilities & Equity
3,0443,1453,1163,2793,3863,149
Total Debt
90.19209.49217.13253.07285.61312.28
Net Cash (Debt)
624.88575.75583.14483.11370.88181.52
Net Cash Growth
8.08%-1.27%20.71%30.26%104.32%-4.07%
Net Cash Per Share
1.071.051.060.930.690.34
Filing Date Shares Outstanding
534.07534.07534.07534.07534.07534.07
Total Common Shares Outstanding
534.07534.07534.07534.07534.07534.07
Working Capital
973.621,0331,0651,086995.55966.05
Book Value Per Share
4.364.344.424.374.364.39
Tangible Book Value
1,9901,9832,0231,9961,9291,940
Tangible Book Value Per Share
3.733.713.793.743.613.63
Buildings
-1,0911,0021,0011,001978.49
Machinery
-709.05651.9651.59643.1607.56
Construction In Progress
-41.3141.2563.9553.8358.26